Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.

John PapastergiouMichelle DonnellyWilson LiRobert D SindelarBart van den Bemt

Published in: Canadian journal of kidney health and disease (2020)

These results illustrate the prevalence of abnormal renal function among undiagnosed, high-risk patients in the community. Pharmacists, as the most accessible healthcare practitioners, are ideally positioned to utilize novel point-of care technologies to improve access to CKD screening, facilitate follow-up, and increase awareness around the importance of early detection.

Keyphrases

healthcare
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
small cell lung cancer
mental health
risk factors
patient reported outcomes
tyrosine kinase
patient reported